P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE RELATIVE TO TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B PATIENTS TREATED FOR 5 YEARS
Wai Kay Seto1, Ting-Tsung Chang2, Abhijit Chowdhry3, Chi-Yi Chen4, Mustafa Kemal Celen5, Xiaoli Ma6, Mang Ma7, Ajay Duseja8, Ki Tae Yoon9, Wan Cheng Chow10, Leland Yee11, Gregor Weber11, Ms Jin Youn11, John F. Flaherty11, Anuj Gaggar11, Bing Gao11, Gregory Camus11, Eric Bassetti11, Jae Seok Hwang12, Tetshuro Inokuma13..., Young- Suk Lin14, Edward J. Gane15Ver más
1 The University of Hong Kong, Hong Kong, Hong Kong
2 National Cheng-Kung University Hospital, Tainan, Taiwan
3 Institute of Post Graduate Medical Education and Research, Kolkata, India
4 Chia-Yi Christian Hospital, Chia-Yi, Taiwan
5 Dicle U¨Niversitesi Hastanesi Enfeksiyon Hastaliklari Anabilim Dali, Diyarbakir, Turkey
6 Xiaoli Ma, P.C., Philadelphia, USA
7 Zeidler Ledcor Centre, Edmonton, Canada
8 Postgraduate Institute of Medical Education & Research, Chandigarh, India
9 Pusan National University Yangsan Hospital, Yangsan, Korea
10 Singapore General Hospital, Singapore, Singapore
11 Gilead Sciences Inc., Foster City, USA
12 Keimyung University Dongsan Medical Center, Daegu, Korea
13 Kobe City Medical Center General Hospital, Kobe, Japan
14 Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
15 Liver Unit University of Auckland, Grafton, New Zealand
Ver másRead
164
Timeswas read the article
70
Total PDF
94
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 2 | 1 | 3 |
| 2024 June | 13 | 3 | 16 |
| 2024 May | 19 | 6 | 25 |
| 2024 April | 9 | 4 | 13 |
| 2024 March | 9 | 2 | 11 |
| 2024 February | 7 | 7 | 14 |
| 2024 January | 4 | 6 | 10 |
| 2023 December | 1 | 4 | 5 |
| 2023 November | 4 | 6 | 10 |
| 2023 October | 7 | 9 | 16 |
| 2023 September | 3 | 5 | 8 |
| 2023 August | 2 | 4 | 6 |
| 2023 July | 2 | 6 | 8 |
| 2023 June | 1 | 3 | 4 |
| 2023 May | 11 | 4 | 15 |
Show all
